Primary carnitine deficiency and cardiomyopathy

Korean Circulation Journal

Volumn 43, Issue 12, 2013, Pages 785-792

  Fu, Lijun ^a   Huang, Meirong ^a   Chen, Shubao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiomyopathies; Carnitine deficiency; Primary

Indexed keywords

CARNITINE;

CARDIOMYOPATHY; CARNITINE DEFICIENCY; CLINICAL FEATURE; HUMAN; PROGNOSIS; REVIEW;

EID: 84892592258     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2013.43.12.785     Document Type: Review

References (51)

1. Cox GF, Sleeper LA, Lowe AM, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatries 2006;118:1519-31.
2. Cox GF. Diagnostic Approaches to Pediatric Cardiomyopathy of Metabolic Genetic Etiologies and Their Relation to Therapy. Prog Pediatr Cardiol 2007;24:15-25. (Pubitemid 47576679)
3. Tripp ME, Katcher ML, Peters FIA, et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N EngI J Med 1981;305:385-90. (Pubitemid 11063755)
4. Waber U, Valle D, Neill C, DiMauro S, Shug A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982;101:700-5.
5. Pierpont ME, Breningstall GN, Stanley CA, Singh A. Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children. Am Heart J 2000;139(2 Pt 3)596-106.
6. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J 1992;6:3379-86. (Pubitemid 23007103)
7. Glube N, Closs E, Langguth P. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1). Mol Pharm 2007;4:160-8.
8. Flanagan JL Simmons PA, Vehige J, Willcox MD, Garrett CL Role of carnitine in disease. Nutr Metab (Lond) 2010;7:30.
9. Koizumi A, Nozaki J, Ohura T, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 1999;8:2247-54. (Pubitemid 29525340)
10. Lund AM, Joensen F, Hougaard DM, et al. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit Metab Dis 2007;30:341-9.
11. Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis 2013. [Epub ahead of print]
12. Nezu J, Tamai I, Oku A, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. NatGenet 1999;21:91-4. (Pubitemid 29036290)
13. Wang Y, Ye J, Ganapathy V, Longo N. Mutations in the organic cation/ carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 1999;96:2356-60. (Pubitemid 29117919)
14. Tamai I, Ohashi R, Nezu J, et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter 0CTN2. J Biol Chem 1998;273:20378-82. (Pubitemid 28377603)
15. Wu X, Prasad PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Bioehem Biophys Res Commun 1998;246:589-95. (Pubitemid 28420901)
16. Scaglia F, Wang Y, Singh RH, et al. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet Med 1998;1: 34-9. (Pubitemid 128631165)
17. Stanley CA, Bennett MJ. Defects in metabolism of lipid. In: Kliegman RM, Behrman RE, Stanton BF, St. Geme J, Schor N, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: W.B. Saunders Company;2011. p.460-1.
18. Paulson DJ. Carnitine deficiency-induced cardiomyopathy. Mol Cell Bioehem 1998;180:33-41. (Pubitemid 28118801)
19. Chapoy PR, Angelini C, Brown WJ, Stiff JE, Shug AL Cederbaum SD. Systemic carnitine deficiency-a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med 1980;303:1389-94. (Pubitemid 11197527)
20. Shibbani K, Fahed A, Al-Shaar L, et al. Primary carnitine deficiency: Novel mutations and insights into the cardiac phenotype. Clin Genet 2013. [Epub ahead of print]
21. Kilic M, Ozgül RK, Coşkun T, et al. Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency. JlMD Rep 2012;3:17-23.
22. Fu U, Chen SB, Han LS, et al. [Clinical presentation and therapeutic outcomes of carnitine deficiency-induced cardiomyopathy], Zhonghua Er Ke Za Zhi 2012;50:929-34.
23. Stanley CA, DeLeeuw S, Coates PM, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991;30:709-16.
24. Rasmussen J, Kober L Lund AM, Nielsen OW. Primary carnitine deficiency in the faroe islands: Health and cardiac status in 76 adult patients diagnosed by screening. J Inherit Metab Dis 2013. [Epub ahead of print]
25. Lee NC, Tang NL Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab 2010;100:46-50.
26. De Biase I, Champagne NL Schroer R, Pollard LM, Longo N, Wood T. Primary carnitine deficiency presents atypically with long qt syndrome: A case report. JIMD Rep 2012;2:87-90.
27. Amat di San Filippo C, Taylor MR, Mestroni L Botto LD, Longo N. Cardiomyopathy and carnitine deficiency. Mol Genet Metab 2008;94: 162-6.
28. Labarthe F, Benoist JF, Peralta M, et al. Primary carnitine uptake deficiency is associated with short QT syndrome and ventricular fibrillation. 11th International Congress of Inborn errors of Metabolism, San Diego CA, Mol Genet Metab 2009;98:55-6 (Poster 327).
29. Rijlaarsdam RS, van Spronsen FJ, Bink-Boelkens MT, et al. Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Pacing Clin Electrophysiol 2004;27:675-6. (Pubitemid 38648462)
30. El-Hattab AW, Li FY, Shen J, et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspects. Genet Med 2010;12:19-24.
31. Rinaldo P, Stanley CA, Hsu BY, Sanchez LA, Stern HJ. Sudden neonatal death in carnitine transporter deficiency. J Pediatr 1997;131:304-5. (Pubitemid 27495255)
32. Rasmussen J, Nielsen OW, Lund AM, Kober L Djurhuus H. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J Inherit Metab Dis 2013;36:35-41.
33. Matsuishi T, Hirata K, Terasawa K, et al. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy. Neuropediatrics 1985;16:6-12. (Pubitemid 15167474)
34. Tein I, De Vivo DC, Bierman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990;28:247-55. (Pubitemid 20262281)
35. Ferro F, Ouillé A, Tran TA, et al. Long-chain acylcarnitines regulate the hERG channel. PLoS One 2012;7:e41686.
36. Garavaglia B, Uziel G, Dworzak F, Carrara F, DiDonato S. Primary car-nitine deficiency: Heterozygote and intrafamilial phenotypic variation. Neurology 1991;41:1691-3.
37. Xiaofei E, Wada Y, Dakeishi M, et al. Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, 0CTN2. J Gerontol A Biol Sci Med Sci 2002;57:B270-8. (Pubitemid 34741969)
38. Takahashi R, Asai T, Murakami H, et al. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation. Hypertension 2007;50:497-502. (Pubitemid 47312235)
39. Sarafoglou K, Tridgell AH, Bentler K, Redlinger-Grosse K, Berry SA, Schimmenti LA. Cardiac conduction improvement in two heterozygotes for primary carnitine deficiency on L-carnitine supplementation. Clin Genet 2010;78:191-4.
40. Wang Y, Taroni F, Garavaglia B, Longo N. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Hum Mutat 2000; 16:401 -7.
41. Spiekerkoetter U, Huener G, Baykal T, et al. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2. J Inherit Metab Dis 2003;26:613-5. (Pubitemid 37321542)
42. Rose EC, di San Filippo CA, Ndukwe Erlingsson UC, Ardon O, Pasquali M, Longo N. Genotype-phenotype correlation in primary carnitine deficiency. Hum Mutat 2012;33:118-23.
43. Yamak A, Bitar F, Karam P, Nemer G. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: A genotype-phenotype correlation.Clin Genet 2007;72:59-62.
44. Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: An overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2012;7:68.
45. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006;142C:77-85.
46. Helton E, Darragh R, Francis P, et al. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy. Pediatrics 2000;105:1260-70. (Pubitemid 30346896)
47. Kothari SS, Sharma M. L-carnitine in children with idiopathic dilated cardiomyopathy. Indian Heart J 1998;50:59-61. (Pubitemid 28240135)
48. Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J2000; 139(2 Pt 3) :S 120-3.
49. Agnetti A, Bitton L, Tchana B, Raymond A, Carano N. Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up. Int J Cardiol 2013;162:e34-5.
50. Cederbaum SD, Koo-McCoy S, Tein I, et al. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol Genet Metab 2002;77:195-201. (Pubitemid 35333823)
51. Stanley CA. Carnitine deficiency disorders in children. Ann N Y Acad Sci 2004;1033:42-51. (Pubitemid 39656737)